Pellets are spherical or nearly spherical, free-flowing granules with a narrow size distribution, typically varying between 500 and 1500 µm for pharmaceutical applications. They are generally produced via a pelletization process whereby a powder blend consisting of an API and excipients particles is agglomerated into spherical granules. This review article deals with various aspects of the extrusion-spheronization technique. Pelletization is a technique to convert drugs or excipients to small free flowing, spherical or semi spherical units, which are produced by agglomerating fine powdered drugs/ excipients with a binder solution. Pellets range in size, typically, between 0.5 -2 mm. In relation to pharmaceuticals, pellets offer high degree of flexibility in design and development of oral dosage form. Pelletization technique help in the formation of spherical beads or pellets having a diameter 0.5 -1.5 mm which can be eventually coated for preparation of modified release dosage form.
I. INTRODUCTION

Pellets
Small free flowing spherical unit ranging in size, prepared by agglomeration of fine powders called pellets.
• Their size and shape allow their administration as injection and also for oral drug delivery.
• Pellets range in size typical between 0.5-1.5mm,though other sizes could be prepared. [1] Figure 1. Pharmaceutical Pellets
Pellets as a drug delivery system offer not only therapeutic advantages, such as less irritation of the gastro-intestinal tract and a lowered risk of side effects due to dose dumping but also technological advantages, for example, better flow propertiess, less friable dosage form, narrow particale size distribution, ease of coating and uniform packing. [2] . Pellets can be prepared by a special technique called Pelletization.
This technique is referred to an agglomeration process that convert fine powder or granules of bulk drug or excipient in to small , free flowing , spherical or semi spherical pellets .This technique is needed to produce pellets of uniform size with high drug loading capacity and also prevent segregation and dust [3] Figure 2. Dosage forms-pellets
1.2.Characterization of pellets
• Characterization studies for prepared pellets.
• Optimizing the best formula for each drug, based on in vitro drug release studies.
• Formulating the optimized formula into dosage form
• Characterization studies for final dosage form. [4] 1.3. Why pellets
• Excellent stability.
• Dust free round pellets.
• Good flow behavior.
• Easy to dose.
• Compact structure.
• Very low hygroscopicity.
• High bulk density. [1] 2. Pelletization
Pelletization is often referred to as a size-enlargement process that involves the manufacture of agglomerates with a relatively narrow size rang, usually with mean size 0.5 to 2 mm named pellets.
Pellets are small particles typically created by compressing an original material. [5] .Pelletization is a novel drug delivery system; a technique which converts fine powder particles into pellets. These oral multiparticulate drug-delivery systems offer biopharmaceutical advantages with respect to predictable and even distribution and transportation in the gastrointestinal tract. It has many advantages compared to single-unit dosage forms for ease of filling, better flow properties of spherical pellets, sustained, controlled or site-specific drug delivery, even distribution in the GI tract, less GI irritation, good bioavailability, ease of coating and uniform packing. Pelletization is easier and simple technique compared to granulation in order to develop a sitespecific drug delivery system. [6] Multiparticulate dosage forms are gaining much favour over single unit dosage forms because of their potential benefits like predictable gastric emptying, no risk of dose dumping, flexible release patterns, and increased bioavailability with less intra-subject variability [2] Figure 3. Pellets Formation
In recent years, there has been a growing interest in the field of pelletization to produce spherical pellets which can be changed into several dosages forms like tablet and capsule or can be administered as such.
Pelletization involves size enlargement process and if the final agglomerates are spherical in shape in the size range of 0.5-2.0 mm, they are called pellets. [7] Pelletization is a novel drug delivery system; a technique which converts fine powder particles into pellets. These oral multiparticulate drug-delivery systems offer biopharmaceutical advantages with respect to predictable and even distribution and transportation in the gastro-intestinal tract.
Pelletization can be referred as the conversion of fine powder, granules of drug and excipient by the means of agglomeration to small, free flowing spherical subunit referred as pellets. Which are smaller in size (0.5-1.5mm) and intended mostly for oral administration. [8] 3. Historical development
The term pellet has been used by a number of industries to describe a variety of agglomerates produce from diverse raw materials, using different pieces of manufacturing equipment. These agglomerates include fertilizers, animal feeds, iron ores, and pharmaceutical dosage units and thus do not only differ in composition but also different sizes and shapes. as a meant pellets meant different things for different industries . [9] . In industries utilized Also, pelletization is used in various industries, such as agriculture (fertilizers and herbicides), mineral processing (iron ore pelletization), food and detergent industry. [10] Figure 4. History of pelletization 4. Advantages
• They can be divided in to desired dosage strength without process or formulation changes.
• Improve appearance of product.
• Pellets are of small size and have good flow ability compare to powder form.
• Ease of handling, such as filling into capsules
• Incorporation of incompatible ingredients in a single dosage form
• Different release profiles at different sites in the Gastrointestinal tract
• Protection against degradation of active ingredients by oxidation or moisture by providing film coating
• High degree of patient acceptance when filled in capsules due to their elegance as compared to tablets
• Ideal shape for application of film coatings due to low surface to volume ratio
• High drug loading capacity without producing large particles
• Pellets are less susceptible to dose dumping effect and decrease the side effect
• Due to their small size reduction in gastrointestinal irritation compare to tablet
• Pellets reduce variation in gastric emptying rate and intestinal transit time thus reduce inter and intra patient variability
• They can be formulated as sustained, controlled, or site specific delivery of the drug from coated pellets.
• Density increase can be achieved as bulk density of powder is increased by spheronization process.
This can improve the process and packaging.
Disadvantages
• Pellets filling involve capsule filling which can increase the costs
• Tableting of pellets destroy film coating on the pellets.
• The size of the pellets may vary formulation to formulation but usually is in range of 0.05 mm and 2 mm. [11] 6. Requirements of pellets
• Pellets should be of spherical shape and the surface should be smooth so that desired uniform film coating can be done.
• Particle size of pellets should be in range 0.5-1.5 mm.
• The quantity of excipients should be maximum so as to maintain the particle size.
Reason for pelletization
• The pharmaceutical industry has developed a great interest in Pelletization due to a variety of reasons:
• Prevention of segregation of co-agglomerated components, resulting in an improvement of the uniformity of the content.
• Prevention of dust formation, resulting in an improvement of the process safety, as fine powders can cause dust explosions and the respiration of fines can cause health problems.
• Increasing bulk density and decreasing bulk volume.
• The defined shape and weight improves the appearance of the product.
• Improvement of the handling properties, due to the free flowing properties
• Improvement of the hardness and friability of pellets.
Controlled release application of pellets due to the ideal low surface area to volume ratio that provides an ideal shape for the application of film coatings.
Pellets formation and growth
In order to select and optimize any pelletization/granulation process, it is important to understand the fundamental mechanisms of granule formation and growth. However, based on the experiments on the mechanism of pellet formation and growth, the following steps were proposed:
nucleation, coalescence, layering and abrasion transfer. Nucleation is followed by a transition phase, and the growth mechanisms affecting the transition region are coalescence and layering.
Coalescence is defined as the formation of large-sized particles by random collision of well formed nuclei, and the mechanism requires slight excess moisture on the nuclear surface. Although the number of nuclei is progressively reduced, the total mass of the system remains unchanged during this step. The particles, however, undergo a continuous change in size as long as the conditions that lead to the transfer of material exist. [12] Abrasion transfer.
9. Pelletization V/S Granulation:
• Pelletization produces spheroids with high loading API than granules as it require excipients.
• Pelletization is simple, requires less equipments and fast processing than granulation.
• Coating of pellets is easier than coating granules due to their spherical shape and low surface area to volume ratio.
• Pelletization gives better results in formulation of sustained release and controlled release delivery system than granulation.
• Pelletization gives high through put with low wastage unlike in granulation.
• Pellets are easier to produce of uniform shape, size, good flow properties, reproducibility in packing, high strength, low friability and smooth surface with high drug loading capacity which is not possible with granulation. [6] The liquid may be added to or during the agitation stage. Pans, discs, drums, or mixtures may be used to produce pellets by the balling process . [7] 10.1.1 Balling Also known as spherical agglomeration is a pelletisation technique in which finely divided particle or powder upon addition of an appropriate quantity of liquid are converted to spherical particle by continuous rolling or tumbling action.
They can be done either by adding an appropriate amount of liquid into powder called liquid induced agglomeration or subjecting it to high temperature called melt induced agglomeration. Round curvature pans, horizontal drum mixer, and rotatory fluid bed granulator can be used for the production of spherical pellets by balling .
Compaction
A compaction is a form of pressure agglomeration in which drug particles or granules are forced together with or without formulation aids by a mechanical force to generate pellets of well defined shape and sizes. In compression, particles that are pretreated through dry blending or wet granulation followed by drying rearrange themselves to form a closely packed mass. At higher pressure, the particles are forced against each other and undergo elastic and plastic deformation. In extrusion spheronization, first the dry powder mix is agglomerated with the help of a binding liquid. Then it is processed in the extruder to produce high-density extrudates. These extrudates are finally converted to pellets on spheronizer. [8] 10.2.1. Compression
Compression is a pelletization process in which a mixture or blend of active ingredient and excipients are compacted under pressure to generate pellets of define shape and size. The pellets are small enough to be filled into capsule. [13] 
Extrusion / Spheronisation
Extrusion / spheronisation is a multistage process for obtaining pellets with uniform size from wet granulates (extrudates).
The method involves the following main steps:
• The dry mixing of the ingredients, in order to achieve homogenous powder dispersions
• Wet massing, in which the powders are wet mixed to form a sufficiently plastic mass.
• An extrusion stage, in which the wet mass is shaped into cylindrical segments with a uniform diameter;
• The spheronisation stage, in which the small cylinders are rolled into solid spheres (spheroids);
• The drying of the spheroids, in order to achieve the desired final moisture content;
• Screening (optional), to achieve the desired narrow size distribution.
10.2.3.Extrusion
Extrusion consists in applying pressure to a wet mass until it passes through the calibrated openings of a screen or die plate of the extruder and further shaped into small extrudate segments.
As the mass passes through the extruder screen, the resulting extrudates eventually break under their own weight. Usually the extrudates have the same length. The extrudates must have enough plasticity in order to deform, but an excessive plasticity may lead to extrudates which stick to each other as they are collected and further processed in the spheroniser.
The diameter of the segments and the final size of the spheroids depend on the diameter of the openings in the extruder screen. In order to obtain reproductible results, it is recommended to monitor extrusion parameters such as: feed rate, powder consumption, die temperature and compression chamber pressure.
Spheronisation
Spheronisation reffer to the formation of spherical particles from the small rods produced by extrusion. former with a relatively high minimum film-forming temperature (MFT) issued [12] . 
Spray congealing
It is the process in which a drug is allowed to melt, disperse or dissolve in hot melts of gums, waxes or fatty acids, and is sprayed into an air chamber where the temperature is kept below the melting point of the formulation components, to produce spherical congealed pellets. Both immediate and controlled release pellets can be prepared in this process depending on the physiochemical properties of the ingredients and formulation variables [5] • Extend day time and night time activity of the drugs,
• Potential for reduced incidence of side effects,
• Reduced dosage frequency of dosage forms,
• Increased patient compliance, patients who are required to take 2 or more doses of formulation a day are thought to be less likely to forget a dose then if they are required to take 3 or 4 times a day,
• Potential lower daily cost to patient due to fewer dosage units.
Chemically incompatible products
At times such ingredients are required to be delivered in a single dose. In the compressed tablet dosage form separate tablets would have to be administered, but the pellets can be administered in a single capsule.
Varying dosage without reformulation
Pellets have excellent flow properties, due to this; they can be conveniently used for Filling capsules and the manufacturer can vary the dosage by varying the capsule size without reformulating the product. [12] 13.Conclusion 
